Protalix Biotherapeutics Inc (NYSE American:PLX)

0.4316
Delayed Data
As of Apr 24
 +0.0016 / +0.37%
Today’s Change
0.42
Today|||52-Week Range
1.06
-34.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash55.2M76.7M63.8M51.8M
 
 
 
 
 
Short Term Investment Cash-31.6M21.6M-13.0M-12.0M
 
 
 
 
 
Cash & Short Term Investments55.2M76.7M63.8M51.8M
 
 
 
 
 
 
ReceivablesReceivables1.9M0.00693.0K1.7M
 
 
 
 
 
InventoriesInventories6.7M5.8M5.2M7.8M
 
 
 
 
 
 
Current AssetsPrepaid Expenses369.0K408.0K416.0K433.0K
 
 
 
 
 
Other Current Assets1.4M3.0M1.8M878.0K
 
 
 
 
 
Current Assets65.5M85.9M71.9M62.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross32.7M33.5M34.3M35.1M
 
 
 
 
 
Depreciation-21.5M-23.8M-25.6M-27.5M
 
 
 
 
 
Other Assets1.7M1.6M1.7M1.9M
 
 
 
 
 
Total Assets78.5M97.3M82.2M72.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.0M3.6M4.0M7.5M
 
 
 
 
 
Short Term Debt0.000.0053.9M5.9M
 
 
 
Accrued Expenses12.8M2.1M4.2M5.3M
 
 
 
 
 
Other Current Liabilities21.0M6.5M7.1M7.9M
 
 
 
 
 
Other Liabilities26.2M11.2M66.2M22.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt67.5M72.1M23.6M46.3M
 
 
 
 
 
Other Liabilities912.0K0.000.005.1M
 
 
 
Total Liabilities134.1M86.4M92.2M103.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.00--0.000.00--
Common Equity-55.6M10.9M-10.0M-31.3M
 
 
 
 
 
Total Shareholder Equity-55.6M10.9M-10.0M-31.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding93.6M99.8M124.1M143.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.